[Antimeningococcal vaccination in member States of the Organization for Coordination and Cooperation in the Control of Major Epidemics].
D000293:Adolescent; D000349:Africa; D000907:Antibodies, Bacterial / Q000032:analysis; D000917:Antibody Formation; D001428:Bacterial Vaccines / Q000008:administration & dosage; D002648:Child; D002675:Child, Preschool; D004196:Disease Outbreaks / Q000517:prevention & control; D004352:Drug Resistance, Microbial; D005260:Female; D006801:Humans; D007223:Infant; D007271:Injections, Intradermal; D007279:Injections, Subcutaneous; D007391:International Cooperation; D008297:Male; D008585:Meningitis, Meningococcal / Q000401:mortality / Q000517:prevention & control*; D008589:Meningococcal Infections / Q000517:prevention & control*; D009345:Neisseria meningitidis / Q000187:drug effects; D013412:Sulfadimethoxine / Q000494:pharmacology; D013421:Sulfamethoxypyridazine / Q000494:pharmacology; D014611:Vaccination
D000907:Antibodies, Bacterial; D001428:Bacterial Vaccines; D013412:Sulfadimethoxine; D013421:Sulfamethoxypyridazine
La vaccination antiméningococcique dans les Etats membres de l'OCCG.